Andrea Pensotti

Dr. Andrea Pensotti

Università Campus Bio-Medico, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Oncology Reports
Verified
Journal Article
Open access
PDF file
Andrea PensottiAndrea Pensotti
Andrea Pensotti
MBMariano Bizzarri
Mariano Bizzarri
MBMarta Bertolaso
Marta Bertolaso
Different experimental models reveal that malignant cancer cells can be induced to change their phenotype into a benign one. This phenotypic transformation, confirmed both in vitro and in vivo, currently is known as ‘tumor reversion‘. This evidence raises a radical question among current cancer models: Is cancer reversible? How do genetic and epigenetic alterations hierarchically relate? Understanding the mechanisms of ‘tumor reversion’ represents a key point in order to evolve the actual cancer models and develop new heuristic models that can possibly lead to drugs that target epigenetic mechanisms, for example epigenetic drugs. Even though evidence of tumor reversion dates back to the 1950s, this remains a completely new field of research recently re‑discovered thanks to the interest in cell reprogramming research, developmental biology and the increasing understanding of epigenetic mechanisms. In the current review, a comprehensive review of all the main experimental models on tumor reversion was presented.

Verified
Journal Article
Open access
PDF file
SPSara Proietti
Sara Proietti
ACAlessandra Cucina
Alessandra Cucina
Andrea PensottiAndrea Pensotti
Andrea Pensotti
Pier Mario BiavaPier Mario Biava
Pier Mario Biava
MMMirko Minini
Mirko Minini
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
Some yet unidentified factors released by both oocyte and embryonic microenvironments demonstrated to be non-permissive for tumor development and display the remarkable ability to foster cell/tissue reprogramming, thus ultimately reversing the malignant phenotype. In the present study we observed how molecular factors extracted from Zebrafish embryos during specific developmental phases (20 somites) significantly antagonize proliferation of breast cancer cells, while reversing a number of prominent aspects of malignancy. Embryo extracts reduce cell proliferation, enhance apoptosis, and dramatically inhibit both invasiveness and migrating capabilities of cancer cells. Counteracting the invasive phenotype is a relevant issue in controlling tumor spreading and metastasis. Moreover, such effect is not limited to cancerous cells as embryo extracts were also effective in inhibiting migration and invasiveness displayed by normal breast cells undergoing epithelial–mesenchymal transition upon TGF-β1 stimulation. The reversion program involves the modulation of E-cadherin/β-catenin pathway, cytoskeleton remodeling with dramatic reduction in vinculin, as well as downregulation of TCTP and the concomitant increase in p53 levels. Our findings highlight that—contrary to the prevailing current “dogma”, which posits that neoplastic cells are irreversibly “committed”—the malignant phenotype can ultimately be “reversed”, at least partially, in response to environmental morphogenetic influences.

1 February 2022 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
SPSara Proietti
Sara Proietti
ACAlessandra Cucina
Alessandra Cucina
Andrea PensottiAndrea Pensotti
Andrea Pensotti
Andrea FusoAndrea Fuso
Andrea Fuso
CMCinzia Marchese
Cinzia Marchese
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri

24 April 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
Andrea PensottiAndrea Pensotti
Andrea Pensotti
MBMarta Bertolaso
Marta Bertolaso
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
A growing number of studies shows that it is possible to induce a phenotypic transformation of cancer cells from malignant to benign. This process is currently known as “tumor reversion”. However, the concept of reversibility hardly fits the current cancer models, according to which gene mutations are considered the primary cause of cancer. Indeed, if gene mutations are causative carcinogenic factors, and if gene mutations are irreversible, how long should cancer be considered as an irreversible process? In fact, there is some evidence that intrinsic plasticity of cancerous cells may be therapeutically exploited to promote a phenotypic reprogramming, both in vitro and in vivo. Not only are studies on tumor reversion highlighting a new, exciting research approach, but they are also pushing science to look for new epistemological tools capable of better modeling cancer.

1 May 2020 in Drug Discovery Today
Verified
Journal Article
Closed access
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
Alessandro GiulianiAlessandro Giuliani
Alessandro Giuliani
NMNoemi Monti
Noemi Monti
RVRoberto Verna
Roberto Verna
Andrea PensottiAndrea Pensotti
Andrea Pensotti
ACAlessandra Cucina
Alessandra Cucina

26 July 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
MBMariano Bizzarri
Mariano Bizzarri
Alessandro GiulianiAlessandro Giuliani
Alessandro Giuliani
Andrea PensottiAndrea Pensotti
Andrea Pensotti
EREmanuele Ratti
Emanuele Ratti
MBMarta Bertolaso
Marta Bertolaso
The fall of reductionist approaches to explanation leaves biology with an unescapable challenge: how to decipher complex systems. This entails a number of very critical questions, the most basic ones being: “What do we mean by ‘complex’?” and “What is the system we should look for?” In complex systems, constraints belong to a higher level that the molecular one and their effect reduces and constrains the manifold of the accessible internal states of the system itself. Function is related but not deterministically imposed by the underlying structure. It is quite unlikely that such kind of complexity could be grasped by current approaches focusing on a single organization scale. The natural co-emergence of systems, parts and properties can be adopted as a hypothesis-free conceptual framework to understand functional integration of organisms, including their hierarchical or multilevel patterns, and including the way scientific practice proceeds in approaching such complexity. External, “driving” factors – order parameters and control parameters provided by the surrounding microenvironment – are always required to “push” the components’ fate into well-defined developmental directions. In the negative, we see that in pathological processes such as cancer, organizational fluidity, collapse of levels and dynamic heterogeneity make it hard to even find a level of observation for a stable explanandum to persist in scientific practice. Parts and the system both lose their properties once the system is destabilized. The mesoscopic approach is our proposal to conceptualizing, investigating and explaining in biology. “Mesoscopic way of thinking” is increasingly popular in the epistemology of biology and corresponds to looking for an explanation (and possibly a prediction) where “non-trivial determinism is maximal”: the “most microscopic” level of organization is not necessarily the place where “the most relevant facts do happen.” A fundamental re-thinking of the concept of causality is also due for order parameters to be carefully and correctly identified. In the biological realm, entities have relational properties only, as they depend ontologically on the context they happen to be in. The basic idea of a relational ontology is that, in our inventory of the world, relations are somehow prior to the relata (i.e., entities).